Filspari
Payments companies reported to CMS as associated with Filspari. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Filspari, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Filspari
These are the largest totals companies reported as associated with Filspari. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ashte Collins | Washington, DC | Nephrology (Internal Medicine) | $79,555.14 |
| James Chevalier | New York, NY | Nephrology (Internal Medicine) | $70,710.04 |
| Luis Velez | San Antonio, TX | Nephrology (Internal Medicine) | $66,644.82 |
| Jessica Coleman | Beaufort, SC | Nephrology (Internal Medicine) | $65,902.18 |
| Abdul Abdellatif | Webster, TX | Nephrology (Internal Medicine) | $39,590.60 |
| Anand Reddy | Odessa, TX | Nephrology (Internal Medicine) | $36,444.28 |
| Marco Bonilla | Chicago, IL | Nephrology (Internal Medicine) | $35,396.50 |
| Yasir Qazi | Orange, CA | Nephrology (Internal Medicine) | $34,950.68 |
| Derek Larson | Creve Coeur, MO | Nephrology (Internal Medicine) | $33,632.89 |
| Sheldon Shore | Atlanta, GA | Nephrology (Internal Medicine) | $31,191.55 |
Prescribed Filspari?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.